Tag Archives: IBB

best things to invest in now

House Speaker Paul Ryan of Wis. arrives for a news conference on Capitol Hill in Washington, Thursday, March 2, 2017. (AP Photo/J. Scott Applewhite)

For weeks (or, let’s be honest, years), Republicans in Congress have vowed to repeal the Affordable Care Act. Now, they’re finally showing their hand on what that repeal and replacement might look like.

The Act, sometimes....More>>>

Top 10 High Tech Stocks To Buy Right Now

On the heels of attending the International Metal Writers conference in Vancouver, BC this week, Nexus Gold Corp (OTC: NXXGF, TSX: NXS.V) is receiving positive coverage of its stock by multiple investment and financial analysis sites. Despite being part of the larger down day on Wall Street today, Nexus Gold’s stock has fared well, particularly in the past 30 days.

....More>>>

Top 10 Undervalued Stocks To Buy For 2018

Our Long Idea reports aim to identify those firms that the market has overlooked and that, when analyzed beyond standard metrics, are significantly undervalued. These hidden gems provide excellent upside potential to any portfolio, with little downside risk.

In addition to individual Long Ideas, we provide Model Portfolios that provide well-screened lists of companies based on specific criteria....More>>>

investing in shares

Five years ago I met with participants in the New York Teamsters Road Carriers Local 707 Pension Fund who wanted an answer to the question of how their pension, which was fully funded in 2000, could be on the brink of insolvency. What caused their pension to plummet in value in the past decade-plus? Was the demise entirely unforeseeable, due to unknowable market forces or was foul-play involved?

....More>>>

investment news

Target (NYSE:TGT), America’s second-largest discount retailer, shocked the investment community with a fiscal fourth quarter (ended Jan. 31, 2017) earnings miss. Management also slashed guidance for fiscal 2017 to a midpoint of $4.00 from analyst estimates of about $5.34.

Shares that had fetched above $85 during 2015 and north of $84 last spring opened at $57.41 on Tuesday. CNBC commentators....More>>>

Top Growth Stocks To Invest In 2017

Apogee Enterprises Inc (NASDAQ:APOG) files its latest 10-K with SEC for the fiscal year ended on February 28, 2017. Apogee Enterprises Inc is engaged in the design and development of value-added glass solutions for enclosing commercial buildings and framing art. Apogee Enterprises Inc has a market cap of $1.71 billion; its shares were traded at around $54.52 with a P/E ratio of 18.43 and P/S ratio....More>>>

stock software

William Patalon III

After reading our Private Briefing update on the growth strategy being employed by miner Goldcorp Inc. (NYSE: GG), subscriber John P. sent me this note over the weekend:

“Good report on GG: I like this one a lot – it may go to $50.”

We’re glad when we deliver research and perspective that you folks find valuable.

Today....More>>>

us stock prices

All three initial public offerings (IPOs) on last week’s calendar were, in fact, completed, but the results were mixed at best. That’s more than we can say for the full year, though, which had the distinction of being the worst for IPOs on a dollar basis since 2003 and the worst since 2009 on a volume basis.

Online travel company Travel BV (NASDAQ: TRVG), better known as trivago,....More>>>

Pfizer Near A Technical Breakout

Pfizer (NYSE:PFE) has been gaining a lot of momentum recently with its share price having risen almost 7% since the 24th of January. The stock has been riding the biotech wave since the complex bottomed back in November but also has traded strongly since it announced its fourth quarter results at the end of January. Although the company missed earnings expectation in Q4 due to established....More>>>

Should You Buy Gilead Sciences, Inc (GILD) Stock Ahead Of Q4 Earnings?


Flickr

Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in....More>>>